Cilnidipine/Tadalafil

西尼地平/他达拉非

Report date: 2024/12/19 17:16:19

Base Information

Drug NameCilnidipine/Tadalafil
Drug Alias NameCilnidipine/tadalafil(Aisa Pharma)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated L-type calcium channel blockersVoltage-gated calcium channel blockersPhosphodiesterase 5A inhibitors
TargetsVoltage-gated L-type calcium channelVoltage-gated calcium channelPhosphodiesterase 5A
Therapy Area/IndicationsScleroderma, SystemicRaynaud Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes CilnidipineTadalafil
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsScleroderma, SystemicRaynaud Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A